Is American Express Stock Going Lower?
American Express Company (NYSE:AXP) has long been a Buffett favorite…
Sell
41
NATR Quote, Financials, Valuation and Earnings
Last price:
$14.26
Seasonality move
:
-1.26%
Day range:
$14.22 - $14.51
52-week range:
$10.81 - $21.72
Dividend yield:
0%
P/E ratio:
16.22x
P/S ratio:
0.62x
P/B ratio:
1.68x
Volume:
26.5K
Avg. volume:
35.6K
1-year change:
-17.37%
Market cap:
$263.6M
Revenue:
$445.3M
EPS (TTM):
$0.88
Analysts' Opinion
-
Consensus RatingNatures Sunshine Products has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $22.00, Natures Sunshine Products has an estimated upside of 54.17% from its current price of $14.27.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $21.00 representing 100% downside risk from its current price of $14.27.
Fair Value
-
According to the consensus of 2 analysts, Natures Sunshine Products has 54.17% upside to fair value with a price target of $22.00 per share.
NATR vs. S&P 500
-
Over the past 5 trading days, Natures Sunshine Products has underperformed the S&P 500 by -2.49% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Natures Sunshine Products does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Natures Sunshine Products has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Natures Sunshine Products reported revenues of $114.6M.
Earnings Growth
-
Natures Sunshine Products has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Natures Sunshine Products reported earnings per share of $0.23.
Enterprise value:
191M
EV / Invested capital:
--
Price / LTM sales:
0.62x
EV / EBIT:
8.39x
EV / Revenue:
0.43x
PEG ratio (5yr expected):
0.14x
EV / Free cash flow:
15.06x
Price / Operating cash flow:
21.58x
Enterprise value / EBITDA:
5.31x
Gross Profit (TTM):
$317.9M
Return On Assets:
6.97%
Net Income Margin (TTM):
3.82%
Return On Equity:
10.74%
Return On Invested Capital:
10.71%
Operating Margin:
4.61%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $437.1M | $439.1M | $445.1M | $111.2M | $114.6M | |
| Gross Profit | $312.9M | $317M | $317.9M | $81.2M | $81.8M | |
| Operating Income | $19.6M | $17.2M | $21.3M | $5.8M | $5.3M | |
| EBITDA | $28M | $28.1M | $36M | $9M | $8.8M | |
| Diluted EPS | $0.55 | $0.41 | $0.88 | $0.15 | $0.23 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $145M | $150.7M | $142.8M | $160.2M | $163.5M | |
| Total Assets | $237.4M | $239.8M | $223.5M | $239.9M | $245.3M | |
| Current Liabilities | $65.8M | $70.4M | $63.9M | $73.3M | $67.2M | |
| Total Liabilities | $89.2M | $92.1M | $81.8M | $87.9M | $82.7M | |
| Total Equity | $148.2M | $147.6M | $141.8M | $152M | $162.6M | |
| Total Debt | $6.7M | $3.3M | $1.5M | $216K | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $11.5M | $35.2M | $22.7M | $14.4M | $9.6M | |
| Cash From Investing | -$6.7M | -$12.1M | -$10M | -$4.5M | -$1.7M | |
| Cash From Financing | -$17.6M | -$4.3M | -$13.9M | -$1.6M | -$1M | |
| Free Cash Flow | $4.7M | $23.1M | $12.7M | $9.9M | $7.9M | |
NATR
Sector
Market Cap
$263.6M
$311.5M
Price % of 52-Week High
65.7%
71.78%
Dividend Yield
0%
0%
Shareholder Yield
5.05%
2.67%
1-Year Price Total Return
-17.37%
-13.75%
Beta (5-Year)
0.965
0.502
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$14.27
200-day SMA
Sell
Level
$15.27
Bollinger Bands (100)
Sell
Level
13.13 - 15.55
Chaikin Money Flow
Buy
Level
5.2M
20-day SMA
Sell
Level
$14.65
Relative Strength Index (RSI14)
Sell
Level
38.26
ADX Line
Buy
Level
14.74
Williams %R
Neutral
Level
-67.2355
50-day SMA
Sell
Level
$15.35
MACD (12, 26)
Sell
Level
-0.33
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Sell
Level
-2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.9273)
Buy
CA Score
(Annual)
Level (1.1937)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.4063)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
Stock Forecast FAQ
In the current month, NATR has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NATR average analyst price target in the past 3 months is $22.00.
-
Where Will Natures Sunshine Products Stock Be In 1 Year?
According to analysts, the consensus estimate is that Natures Sunshine Products share price will rise to $22.00 per share over the next 12 months.
-
What Do Analysts Say About Natures Sunshine Products?
Analysts are divided on their view about Natures Sunshine Products share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Natures Sunshine Products is a Sell and believe this share price will drop from its current level to $21.00.
-
What Is Natures Sunshine Products's Price Target?
The price target for Natures Sunshine Products over the next 1-year time period is forecast to be $22.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NATR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Natures Sunshine Products is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NATR?
You can purchase shares of Natures Sunshine Products via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Natures Sunshine Products shares.
-
What Is The Natures Sunshine Products Share Price Today?
Natures Sunshine Products was last trading at $14.26 per share. This represents the most recent stock quote for Natures Sunshine Products. Yesterday, Natures Sunshine Products closed at $14.27 per share.
-
How To Buy Natures Sunshine Products Stock Online?
In order to purchase Natures Sunshine Products stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
QMCO alert for Jan 18
Quantum [QMCO] is down 15.61% over the past day.
Buy
51
QRVO alert for Jan 18
Qorvo [QRVO] is up 14.47% over the past day.
Sell
31
ATEX alert for Jan 18
Anterix [ATEX] is up 11.14% over the past day.
